-
Most Recent
Search Results
240 results for ANAD
Biotech Stocks That Could Double in 2016: Acadia Pharmaceuticals (ACAD)
ACAD stock may look expensive, but it’s still going to double next year thanks to a new drug with a Breakout Therapy designation.
Why Anacor Pharmaceuticals Inc (ANAC), Memorial Resource Development Corp (MRD) and Tribune Publishing Co (TPUB) Are 3 of Today’s Best Stocks
A revival of Merger Monday explains why ANAC, MRD and TPUB are three of today’s best stocks.
Trade of the Day: Speculative ACAD Stock Could Pop 25%
ACADIA Pharmaceuticals Inc. is trading in a well-defined bull channel and just flashed a buy signal.
Acadia Pharmaceuticals Inc. (ACAD) Flirts With a Pfizer Inc. (PFE) Buyout
Acadia stock took a big leap on rumors that Pfizer (PFE) is interested in a buyout. But ACAD stock investors shouldn’t get too excited yet.
Is AIAD Stock the Next DWAC? What to Know as Brad Parscale Boosts the Penny Stock.
A tweet from Brad Parscale has sent AIAD stock skyrocketing. Here’s what investors should know about this potential Trump trade.
Tread Very Carefully When Investing in AnaptysBio Inc
ANAB is up on positive clinical studies posted in the last few months. But the small sample size and risks ahead could hurt the stock…
Why Is Acadia Pharmaceuticals (ACAD) Stock Down 18% Today?
Acadia Pharmaceuticals stock is falling on Tuesday as investors in ACAD react to its failed Phase 3 clinical trial of pimavanserin.
AnaptysBio Earnings: Why ANAB Stock Is Plunging 72%
AnaptysBio (ANAB) earnings for the antibody development company’s third quarter of 2019 have ANAB stock taking a dive on Friday.
Why Is Acadia Pharmaceuticals (ACAD) Stock Down 33% Today?
Today, investors in Acadia Pharmaceuticals and ACAD stock are in selling mode. The FDA gave a thumbs down on a key drug.
ACAD Stock: The Bad News That Has Acadia Pharmaceuticals Plunging Today
Acadia Pharmaceuticals (ACAD) stock is taking a beating on Tuesday after revealing an update from the FDA for one of its drugs.
9 Biotechnology Stocks to Buy Now
This week, nine Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
5 Insurance Stocks to Sell Now
For the current week, the overall ratings of five insurance stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”)…
Trump Stocks Alert: What Is Going on With DWAC, PHUN, CFVI, AIAD Stocks Today?
The Trump stocks are down today following yesterday’s rise spurred by AIAD. Here’s what you need to know about the next few months.
MMAT Stock Alert: Meta Materials Hits 500 Patents
Meta Materials recently filed its 500th patent, reaching a key milestone. Here’s why MMAT stock is still sinking despite the news.
QuantumScape’s Alpha-2 Milestone: A Quantum Leap for QS Stock or a False Start?
The solid-state battery maker achieved yet another key goal it set for itself but is that enough to justify bidding up the stock?
The Science Behind Kensington Capital Could Electrify Your Portfolio
Solid-state batteries (SSBs) represent the future of electric vehicles, bolstering the narrative for KCAC stock. However, investors should know what makes SSBs distinct — and…
5 Biotechnology Stocks to Sell Now
This week, the overall grades of five Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
3 Undervalued Insurance Stocks to Buy Now
Insurance stocks have taken a hit in the past few years, but they’re overdue for a comeback. Try these 3 bargain insurance stocks.
Biggest Movers in Healthcare Stocks Now – THRX ACHN NLNK NKTR
Healthcare stocks finished up broadly on Wall Street today, with the sector seeing an overall increase of 2.1%.
2 – 10 of 240 results
